Beyond SEO: New Free Tool Audits Life Science AI Search Visibility

LIVERPOOL, England and BOSTON – March 31, 2026 – As artificial intelligence fundamentally reshapes how professionals discover information, a UK-based marketing agency has launched a tool to help life science companies navigate this new terrain. Marzipan, a B2B agency specializing in the life sciences, today released its Free AEO Audit Tool, designed to measure a company's visibility within AI-powered search platforms like ChatGPT, Perplexity, and Google's AI Overviews.

The launch addresses a growing concern in highly specialized industries: a digital 'blind spot' where companies are invisible to the AI models that are increasingly becoming the first point of contact for researchers, investors, and procurement teams. The new discipline, termed Answer Engine Optimization (AEO), represents a significant evolution from traditional Search Engine Optimization (SEO), focusing not on ranking in a list of links, but on being included and accurately represented in AI-generated answers.

The Growing 'AI Blind Spot' in Scientific Discovery

For decades, digital marketing in the life sciences has centered on being discoverable through keyword searches on platforms like Google. However, the paradigm is shifting. Industry experts and recent data indicate that decision-makers, from lab researchers to commercial leaders, are now posing complex, strategic questions directly to large language models (LLMs). These AI systems respond not with a list of websites, but with synthesized summaries and direct recommendations, often presenting a shortlist of only three to seven relevant companies or solutions.

Being excluded from these AI-generated shortlists effectively renders a brand invisible during the critical initial discovery phase. This emerging 'AI blind spot' is a significant threat, as companies may be unaware that they are being omitted from key conversations. Research highlights that life science buyers are already using these tools to compare vendor capabilities and validate credibility long before initiating traditional sales interactions.

This lack of visibility is compounded by a lack of trust. A recent poll from the Pistoia Alliance, a global non-profit for life sciences R&D, revealed that over a quarter of life science professionals are unaware of the scientific content their own organization's AI models are trained on. This gap can lead to AI outputs based on incomplete or untraceable evidence, eroding confidence in the results. For marketers, this elevates AEO from a simple traffic-generation problem to a critical governance and brand perception challenge. Success is no longer measured in clicks, but in a brand's ability to be consistently and accurately referenced by trusted AI platforms.

A New Toolkit for an Evolving Landscape

Marzipan's Free AEO Audit Tool aims to provide the clarity that life science companies urgently need. The tool, available on the agency's website, delivers a comprehensive report in approximately 90 seconds by analyzing a company's digital presence across four critical dimensions:

• AI Visibility: Measures how frequently and prominently a brand appears in answers generated by major LLMs for relevant industry queries.
• Technical Signals: Assesses the underlying technical health of a website, including its use of structured data and overall crawlability, which are crucial for AI comprehension.
• E-E-A-T: Evaluates the content's Experience, Expertise, Authoritativeness, and Trustworthiness—key signals that AI models use to determine the quality and reliability of information.
• Competitive Positioning: Benchmarks a company's AI visibility against that of its direct competitors, providing crucial market context.

"Traditional SEO remains important, but it is no longer the complete picture," said Joe Chamberlain, Head of Digital Marketing at Marzipan, in the company's announcement. "AI platforms are becoming a primary discovery channel for life science professionals evaluating products and services. Companies that do not understand how they appear in these results are operating with a blind spot. This tool gives them that visibility for free."

By requiring no account creation or payment, the tool is positioned to give a wide range of companies—from startups to established enterprises—their first data-driven look into their AEO performance.

From Keywords to Conversations: The Rise of AEO

The emergence of AEO signifies a fundamental shift in content strategy. Where SEO often prioritized keywords and backlinks to rank for specific search terms, AEO demands a more holistic approach. Because users are asking conversational questions, AI models favor content that is comprehensive, well-structured, and provides clear, authoritative answers.

This means that simply producing blog posts targeting keywords is no longer sufficient. To achieve visibility in the AI era, life science marketers must focus on creating a robust ecosystem of content that demonstrates deep expertise. This includes detailed technical specifications, peer-reviewed publications, case studies, and comprehensive guides that are interconnected and easily digestible for AI crawlers. Structured data, such as schema markup, becomes more important than ever, as it provides explicit context to search engines about a page's content, relationships, and authorship.

Outdated, thin, or duplicated content, which might have been overlooked in the past, now poses a greater risk, as AI systems are programmed to prioritize the most current and authoritative sources. The new goal for content creators is to become a primary, citable source for the AI models themselves, ensuring the brand's narrative is woven directly into the answers that shape customer decisions.

Democratizing Intelligence for a Niche Sector

By offering a specialized AEO audit at no cost, Marzipan is effectively democratizing access to critical business intelligence within the competitive life sciences sector. For smaller biotech firms or diagnostic startups with limited marketing budgets, understanding their AI visibility has been a difficult, if not impossible, task. Such tools provide an opportunity to identify weaknesses and compete on a more level playing field with larger, more established pharmaceutical and medtech corporations.

This strategic move also positions the agency, which has over two decades of dedicated experience in the life sciences, as a thought leader in this nascent field. Providing a high-value tool for free can build trust and demonstrate expertise, attracting clients who recognize the urgency of adapting their digital strategy.

As the influence of AI-driven answer engines continues to grow, the ability to measure and optimize for visibility within them will become a standard component of any successful digital marketing program. The introduction of accessible tools focused on niche B2B verticals like life sciences marks a pivotal step in this industry-wide transition, forcing companies to look beyond their website analytics and ask a new, critical question: what is the AI saying about us?